Literature DB >> 2172567

Case management in addictions treatment.

K Graham1, C B Timney.   

Abstract

The need for case management in addictions treatment systems has been recognized for at least 10 years. As more attention is paid to developing this treatment component and as more data are available concerning the implementation of case management in addictions, it is becoming apparent that there is a lack of consensus concerning who should provide case management and how it should be defined. This paper reviews sources of variability of case management services identified in the mental health field and discusses the implications for the development of case management in addictions programs.

Mesh:

Year:  1990        PMID: 2172567     DOI: 10.1016/0740-5472(90)90020-q

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  5 in total

Review 1.  The development and implementation of case management for substance use disorders in North America and Europe.

Authors:  Wouter Vanderplasschen; Richard C Rapp; Judith R Wolf; Eric Broekaert
Journal:  Psychiatr Serv       Date:  2004-08       Impact factor: 3.084

2.  Longitudinal Examination of Medical Staff Utilization in Substance Use Disorder Treatment Organizations.

Authors:  Dail Fields; Paul Roman
Journal:  J Subst Abuse Treat       Date:  2015-07-02

3.  Case management with homeless women: a descriptive study.

Authors:  C Mercier; G Racine
Journal:  Community Ment Health J       Date:  1995-02

Review 4.  Effect of Case Management Interventions for Patients with Substance Use Disorders: A Systematic Review.

Authors:  Louise Penzenstadler; Ariella Machado; Gabriel Thorens; Daniele Zullino; Yasser Khazaal
Journal:  Front Psychiatry       Date:  2017-04-06       Impact factor: 4.157

5.  A Meta-Analysis of the Efficacy of Case Management for Substance Use Disorders: A Recovery Perspective.

Authors:  Wouter Vanderplasschen; Richard C Rapp; Jessica De Maeyer; Wim Van Den Noortgate
Journal:  Front Psychiatry       Date:  2019-04-16       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.